|
|
Article: Scientists at University of Malaga target aphasia.(Clinical report)
- Article from:
- Biotech Week
- Article date:
- July 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research published in the journal Annals of Neurology, "We conducted a randomized, double-blind, placebo-controlled, parallel-group Study of both memantine and constraint-induced aphasia therapy (CIAT) on chronic poststroke aphasia followed by an open-label extension phase. patients were randomized to memantine (20mg/day) or placebo alone during 16 weeks, followed by combined drug treatment with CIAT (weeks 16-18), drug treatment alone (weeks 18-20), and washout (weeks 20-24), and finally, an open-label extension phase of memantine (weeks 24-48)."
"After baseline evaluations, clinical assessments were done at two end points (weeks 16 and 18), ...